29/06/2025
Dear WAVD Committee,
Since attending the Congress, I have been actively involved in disseminating the knowledge I acquired at the congress, especially regarding canine bacterial skin infections: their classification, clinical identification, diagnostic approaches, and treatment. I have placed particular emphasis on promoting the use of topical therapies and on educating about the cautious, evidence-based use of systemic antimicrobial therapy — advocating its use only in specific, justified cases in alignment with current global guidelines.
To achieve this, I have delivered educational talks to veterinarians, veterinary technicians, and veterinary students across several cities in my region. These activities have taken place in veterinary clinics throughout my city and neighboring areas. I have trained veterinary teams, sharing up-to-date knowledge and tools to improve clinical decision-making in dermatological cases.
I was also invited to speak at University of Viña del Mar, where I gave a presentation to recently graduated veterinary doctors from the Class of 2024. I ensured that all these sessions included extended time for questions and discussion, allowing participants to engage fully and clarify their doubts on these important topics.
Furthermore, I enriched my lectures by incorporating key updates from the recently published consensus statement on canine bacterial skin infections, which provided additional context and scientific support for the information I shared. Key topics discussed included:
- The classification of canine pyoderma by histological depth (surface, superficial, and deep) and the rationale behind the treatment choices for each.
- The importance of cytology as a diagnostic tool in confirming bacterial involvement and guiding therapeutic decisions.
- The recommendation of topical antimicrobial therapy as first-line treatment in most cases of surface and superficial pyoderma, while systemic antimicrobials should be reserved for deep infections or refractory cases.
- The need to identify and manage underlying primary conditions such as atopic dermatitis, endocrinopathies, or parasitic diseases, which are often the root causes of recurrent pyoderma.
- When and how to perform bacterial culture and antimicrobial susceptibility testing to ensure responsible antimicrobial use and prevent resistance.
- Strategies for preventing recurrences, including long-term topical management and client education.
I also shared practical tips on cytology techniques, topical product selection, and communication strategies with pet owners to improve compliance and outcomes. These sessions were met with great interest, and the open discussion spaces allowed for the resolution of many clinical doubts from professionals in various levels of experience.
I have attached some photographs of the activities carried out as part of this initiative, and I thank you once again for your support and for advancing global veterinary dermatology education.
Warm regards,
Nicole Jeria Visintini